Pleco Therapeutics
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jonkerbosplein 52, Nijmegen, Gelderland,...Phone Number
+31 611325510Website
www.plecotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Pleco Therapeutics
Pleco Therapeutics is a specialty biopharmaceutical company which aims to extend the life span and enhance the quality of life of patients through its novel Plecoid therapies that have been designed to dramatically increase the effectiveness of current cancer treatments. The company's novel Plecoid therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell, thereby improving the effectiveness of existing chemotherapy. Pleco is headquartered in Nijmegen, the Netherlands, with a U.S. subsidiary, Pleco Therapeutics USA Inc, based in Newark, New Jersey.Explore more
Pleco Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pleco Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Pleco Therapeutics launches new products
Funding: Get notified immidiatlly once Pleco Therapeutics has new funding data
Earning: See what the market has to say on Pleco Therapeutics recently announced quarterly report
Check if Pleco Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Pleco Therapeutics
Pleco Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Pleco Therapeutics had a recent Job posting/layoffs
Check out if Pleco Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Pleco Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Pleco Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pleco Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pleco Therapeutics.
Pleco Therapeutics financials insights
Gather financial insights about Pleco Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$17.3M
Pleco Therapeutics Tech Stack
A closer look at the technologies used by Pleco Therapeutics
Pleco Therapeutics News & Media
Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
NIJMEGEN, Netherlands, Sept. 6, 2022 /PRNewswire/ -- Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer micro-environment today announces the final close of its Series A financing, with total funds raised of €17.3...Pleco Therapeutics Announces Expansion with the Incorporation of a U.S. Subsidiary and the Appointment of Michael Stalhamer as President
NIJMEGEN, Netherlands and NEWARK, N.J., July 26, 2022 /PRNewswire/ -- Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer promoting cellular micro-environment, today announces its expansion, with the incorporation if a U....Pleco Therapeutics Announces €8.7m Strategic Partnership with Hyloris to Progress its Novel Plecoid™ Agent in Acute Myeloid Leukaemia and Small Cell Lung Cancer
NIJMEGEN, Netherlands, Nov. 10, 2021 /PRNewswire/ -- Pleco Therapeutics SA, a specialty biopharmaceutical company developing novel combination chelating agents to detoxify the cancer micro-environment today announces that it has entered into a strategic partnership with Hyloris...Hyloris Broadens Pipeline with Novel Patented Combination Product Candidate in Acute Myeloid Leukaemia and Small Cell Lung Cancer
Liège, Belgium – 10 November 2021, 7:00am CET – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today announces that it has entered into a strategic partnership with Pleco Therapeutics to develop a Plecoid™ Agent, a novel combination product of chelating agents for the treatment of Acute Myeloid Leukaemia (AML) and Small Cell Lung Cancer (SCLC).
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pleco Therapeutics
Sign Up For FreeTo access detailed company insights
Pleco Therapeutics is a specialty biopharmaceutical company which aims to extend the life span and enhance the quality of life of patients through its novel Plecoid therapies that have been designed to dramatically increase the effectiveness of current cancer treatments. The company's novel Plecoid therapies have the potential to positively change... Read More
